Welcome to the Peptide Therapeutics Foundation
The Peptide Therapeutics Foundation is a not-for-profit 501C(3), established in 2008 to promote research and development of peptide therapeutics. The Foundation and Symposium are supported by the following corporate sponsors: AstraZeneca, Ferring Research Institute Inc., Novo Nordisk, the PolyPeptide Group, Zealand Pharma, and Zydus Cadila. To learn more about our corporate sponsors and board members click here.
Click here for an overview of the peptide therapeutic landscape, including historical perspectives, molecular characteristics, regulatory benchmarks, and a therapeutic area breakdown.
Peptide Therapeutic Foundation announces the recipients of the Ferring Research Institute Innovation Grants Program for 2018:
Fiona Cousins – Hudson Institute of Medical Research, Monash University
Laurent Derré – University Hospital of Lausanne (CHUV)
Marta Dueñas – Fundación para la Investigación Hospital 12 de Octubre
Tracey Edgell – Hudson Institute of Medical Research, Monash University
Pradipta Ghosh – University of California, San Diego
Emmet Hirsch – NorthShore University HealthSystem
Sarah Marshall – Monash University
Harmeet Malhi – Mayo Clinic
Hiroshi Miyamoto – University of Rochester
Meet the 2017 Recipients:
October 24-25, 2019
The Salk Institute